Genomic_JJ
organization_NN
,_,
sequence_NN
,_,
and_CC
transcriptional_JJ
regulation_NN
of_IN
the_DT
human_JJ
eotaxin_NN
gene_NN
._.

Eotaxin_NN
is_VBZ
an_DT
eosinophil_NN
specific_JJ
beta-chemokine_NN
assumed_VBN
to_TO
be_VB
involved_VBN
in_IN
eosinophilic_JJ
inflammatory_JJ
diseases_NNS
such_JJ
as_IN
atopic_JJ
dermatitis_NN
,_,
allergic_JJ
rhinitis_NN
,_,
asthma_NN
and_CC
parasitic_JJ
infections_NNS
._.

Its_PRP$
expression_NN
is_VBZ
stimulus_NN
-_:
and_CC
cell-specific_JJ
._.

We_PRP
here_RB
describe_VBP
the_DT
genomic_JJ
organization_NN
-LRB-_-LRB-
3_CD
exons_NNS
of_IN
132_CD
,_,
112_CD
and_CC
542_CD
bp_NN
and_CC
2_CD
introns_NNS
of_IN
1211_CD
and_CC
378_CD
bp_NN
-RRB-_-RRB-
and_CC
sequence_NN
including_VBG
3_CD
kb_NN
of_IN
DNA_NN
from_IN
the_DT
immediate_JJ
5_CD
'_``
upstream_JJ
region_NN
of_IN
the_DT
human_JJ
eotaxin_NN
gene_NN
._.

Among_IN
the_DT
regulatory_JJ
promoter_NN
elements_NNS
potentially_RB
regulating_VBG
eotaxin_NN
gene_NN
expression_NN
and\/or_CC
mediating_VBG
the_DT
effects_NNS
of_IN
anti-inflammatory_JJ
drugs_NNS
we_PRP
identified_VBD
consensus_NN
sequences_NNS
known_VBN
to_TO
interact_VB
with_IN
nuclear_JJ
factors_NNS
like_IN
NF-IL6_NN
,_,
AP-1_NN
,_,
a_DT
NF-kappa-B_NN
like_IN
consensus_NN
sequence_NN
and_CC
gamma-interferon_NN
-_:
as_RB
well_RB
as_IN
glucocorticoid_NN
response_NN
elements_NNS
._.

